SAN DIEGO (AP) _ The Kansas Bioscience Authority is providing $3.7 million for research on cancer, HIV and osteoporosis as well as increased development of new medicines.
The state-created agency announced the investments at a convention in San Diego on Wednesday, saying it hopes to highlight the existing capacity for bioscience research in Kansas.
Lenexa-based ImmunoGenetix Therapeutics Inc. will receive $420,000 to help with a vaccine designed to improve immune responses in patients who are HIV-positive. OsteoGeneX of Kansas City, Kan., will get $375,000 for research on osteoporosis and other bone disorders. Other grantees will receive money to build drug-testing labs and cancer treatments.
The authority is also offering $2.5 million to attract national cancer researchers to work with researchers in Kansas.
(Copyright 2008 by The Associated Press. All Rights Reserved.)
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or firstname.lastname@example.org.